This inventor holds 1 USPTO granted patent. Top assignee: Kanaph Therapeutics Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Dahye Jeon: Innovator in SHP2 Inhibition
Introduction
Dahye Jeon is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for SHP2, a protein associated with various diseases.
Latest Patents
Dahye Jeon holds a patent for an SHP2 inhibitor and its use. The invention relates to a pharmaceutical composition aimed at preventing or treating diseases linked to SHP2. This innovative approach can effectively address health issues associated with this protein.
Career Highlights
Dahye Jeon is currently associated with Kanaph Therapeutics Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Miyeon Kim and Dohyun Park, who contribute to the collaborative efforts at Kanaph Therapeutics Inc. Their teamwork enhances the innovative environment within the company.
Conclusion
Dahye Jeon's work in SHP2 inhibition represents a significant advancement in pharmaceutical research. His contributions are poised to make a meaningful impact on the treatment of diseases related to SHP2.